share_log
Moomoo 24/7 ·  Mar 12 07:48
Ventyx Biosciences Shares Are Trading Higher After Oppenheimer Upgraded the Stock From Perform to Outperform and Announced a $12 Price Target. Also, Wells Fargo Upgraded the Stock From Equal-Weight to Overweight and Raised Its Price Target From $7 to $16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment